Systemic BCG‐osis following intravesical BCG instillation for bladder carcinoma. Issue 10 (15th August 2017)

• Record Type: Journal Article
• Authors: Liaw, Frank; Tan, Yan Yu; Hendry, David
• Is Part Of: Clinical case reports. Volume 5:Issue 10(2017)
• Page Start: 1569
• Page End: 1572
• Publication Date: 2017-08-15
• Subjects: Adverse effects -- Bacillus Calmette‐Guérin -- BCG immunotherapy -- case report -- intravesical BCG -- systemic BCG‐osis; Medicine -- Periodicals; 616.09
• DOI: 10.1002/ccr3.1129
• Languages: English
• ISSNs: 2050-0904

Abstract

Key Clinical Message: Intravesical instillation of Bacillus Calmette‐Guérin (BCG) has been shown to be an effective form of immunotherapy for bladder cancer. This case report describes a patient who develops systemic BCG‐osis following intravesical BCG instillation and demonstrates the importance of being aware of more severe complications associated with BCG immunotherapy. Abstract : Intravesical instillation of Bacillus Calmette‐Guérin (BCG) has been shown to be an effective form of immunotherapy for bladder cancer. This case report describes a patient who develops systemic BCG‐osis following intravesical BCG instillation and demonstrates the importance of being aware of more severe complications associated with BCG immunotherapy.